Drugs / ATG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00226512 | Jul 2004 → ? | acute myeloid leukemia, myelodysplastic syndrome | Hadassah Medical Organization | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00226512 ↗ |
| Modality | Protein / enzyme biologic | “polyclonal rabbit anti-T lymphocyte antibodies (ATG)” NCT00226512 ↗ |